Related Experiment Video
Updated: Jan 4, 2026

10:35
Markerless Gene Deletion by Floxed Cassette Allelic Exchange Mutagenesis in Chlamydia trachomatis
Published on: January 30, 2020
7.1K
Insertional mutagenesis in the zoonotic pathogen Chlamydia caviae
Kimberly Filcek1, Katarina Vielfort2, Samada Muraleedharan2
1Department of Microbial Pathogenesis, University of Maryland, School of Dentistry, Baltimore, MD, United States of America.
Plos One
|November 8, 2019
Summary
Researchers developed genetic tools to study Chlamydia caviae virulence. They disrupted genes for IncA and SinC, finding IncA affects vacuole fusion and SinC impacts in vivo virulence in a chicken embryo model.
Area of Science:
- Microbiology
- Genetics
- Bacterial Pathogenesis
Background:
- Targeted genetic modification is crucial for studying bacterial virulence factors.
- Molecular genetic analysis has advanced in Chlamydia trachomatis but lags in related veterinary Chlamydia species.
- Veterinary Chlamydia spp. cause economic losses and rare human infections.
Purpose of the Study:
- To establish site-specific mutagenesis for disrupting virulence genes in Chlamydia caviae.
- To investigate the roles of secreted effector proteins IncA and SinC in C. caviae.
Main Methods:
- Developed and applied site-specific mutagenesis techniques in C. caviae.
- Generated mutants deficient in IncA and SinC.
- Utilized a chicken embryo infection model to assess virulence.
Main Results:
- Successfully generated C. caviae mutants lacking IncA and SinC.
- Demonstrated that C. caviae IncA is involved in mediating the fusion of bacteria-containing vacuoles.
- Provided the first in vivo evidence for SinC's role in C. caviae virulence using a chicken embryo model.
Conclusions:
- Site-specific mutagenesis is feasible in C. caviae, enabling genetic studies of virulence.
- IncA and SinC are important virulence factors in C. caviae, with distinct roles in host-pathogen interactions.
Related Concept Videos
In-vitro Mutagenesis
15.9K
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
15.9K
Viral Mutations
39.5K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
39.5K
Mutations in Microorganisms
457
Mutations are heritable changes in an organism’s genome involving alterations in the base sequence of DNA or RNA. These changes can influence cellular processes and phenotypic traits, potentially transforming the unaltered wild type into a mutant form. Such changes, termed forward mutations, are pivotal in shaping the genetic diversity of organisms.RNA viruses exhibit the highest mutation rates due to the absence of robust proofreading mechanisms during genome replication. In contrast,...
457
Bacterial Phylum Chlamydiae
379
The phylum Chlamydiae or Chlamydiota is composed of a single order, Chlamydiales. This phylum consists entirely of obligate intracellular parasites that infect eukaryotic hosts. While human pathogens within this group have been studied extensively, the phylum encompasses many species capable of interacting with various eukaryotic organisms. Members of Chlamydiae are typically small cocci, approximately 0.5 μm in diameter, and exhibit a distinctive developmental cycle. As is characteristic...
379

